Laurent Rivory Pro-Vice-Chancellor (Research)
Professor Laurent Rivory is the Pro-Vice-Chancellor (Research) at the University of Sydney. Professor Rivory’s role focuses on the areas where cross-faculty engagement and external partnerships are integral to the academic enterprise.
An important aspect of the role is developing and establishing frameworks and governance arrangements that enable appropriate integration with external partners to increase translation into practice, new capability and impact of the University’s research and education output.
His responsibilities include the large-scale collaborations such as the Charles Perkins Centre and the Brain and Mind Centre, the Core Research Facilities and the management of external partnerships, particularly in health.
He has a strong interest in ensuring that these enable increased scale and translation of health research at the University of Sydney.
Professor Rivory has 20 years’ experience in research and leadership, which has spanned the higher education, hospital and industry sectors.
He is widely recognised for his research in cancer drug pharmacology and has extensive experience in the management of key research programmes in virology, immunology, cancer, RNA therapeutics and diagnostics which were conducted through his appointments at the University of Queensland, the Royal Prince Alfred Hospital, the Université de Bordeaux II and the Fondation Bergonié, and the University of Sydney.
Laurent was recruited to Johnson and Johnson Research in 2002 where he rose to the position of Senior Research Director, Research and Development before returning to the higher education sector to take the role of Director of the Research Strategy Office at the University of New South Wales in 2009.
He has also had previous appointments as Clinical Senior Lecturer at the University of Sydney and as head of the Pharmacology Laboratory, Sydney Cancer Centre, Royal Prince Alfred Hospital, Camperdown.
He is a Committee Member for Bellberry Ltd, which is a not-for-profit provider of HREC services.
He successfully completed the AICD course for company directors while at Johnson and Johnson and has since developed broad experience as a non-executive Director of a number of companies as well as representing various Universities on several national and regional research consortia (Microscopy Australia, National Imaging Facility, Sydney Health Partners etc). Until recently, he was the Chair of the Advisory Committee of the ARC Centre of Excellence for Cognition and its Disorders.